Fibronectin splice variants containing the EIIIA and/or EIIIB exons are prominently expressed in the vasculature of a variety of human tumors but not in normal adult tissues. To understand the functions of these splice variants in physiological as well as tumor angiogenesis, we used EIIIBnull and EIIIA-null strains of mice to examine neovascularization of mouse retinas, pancreatic tumors in Rip-Tag transgenic mice and transplanted melanomas. Contrary to expectations, physiological and tumor angiogenesis were not affected by the absence of either EIIIA or EIIIB splice variants. Tumor growth was also not affected. In addition, the expression levels of smooth muscle alpha actin, believed to be modulated by EIIIA-containing fibronectins, were not affected either. Our experiments show that, despite their tight regulation during angiogenesis, the presence of EIIIA or EIIIB splice variants individually is not essential for neovascularization.
INTRODUCTION.
Angiogenesis is a process whereby new blood vessels develop from the pre-existing vasculature (5) . This process is crucial to provide oxygen and nutrients to a growing tumor mass; without vascular supply, tumors fail to grow beyond 1.5 mm in diameter (15, 25) . Inhibition of tumor angiogenesis leads to inhibition or retardation of tumor growth in animal tumor models (7) . Extracellular milieu plays a prominent role in tumor development by supplying factors that can either enhance (e.g. matrix metalloproteinases (12) , VEGF (28, 2)) or inhibit (e.g. thrombospondin (48) , tumstatin (23)) tumor growth. Extracellular matrix proteins including fibronectin and its splice variants are prominently expressed in and around tumors (32, 10, 47) , but their roles in tumorigenesis are poorly understood. This study investigated the potential functions of fibronectin splice variants, EIIIA and EIIIB, in physiological and tumor angiogenesis.
Fibronectin (FN) is a large modular glycoprotein composed of type I, type II, and type III fibronectin repeats and implicated in numerous cellular processes from cell migration to hemostasis (27, 39) . FN-null embryos and embryoid bodies have scarce numbers of endothelial cells and develop defective vessels (18, 16) , and FN-null embryos die very early in utero from cardiovascular defects (18) (19) (20) . These observations underscore the importance of FN in vascular development.
FN RNA is alternatively spliced at three conserved regions, EIIIA (EDA), EIIIB (EDB), and V (CS-1). Although EIIIA and EIIIB sequences are only 29% identical within a species, interspecies comparisons show that amino acid sequences of EIIIB and EIIIA are highly conserved. For example, the EIIIB and EIIIA segments are100% and 96% identical between mouse and human, respectively. The patterns of expression of these splice variants are also conserved among species. In vivo, EIIIA and EIIIB FN splice variants are expressed around developing blood vessels during embryonic growth (21, 14, 44) when vessels are actively forming and being remodeled, but they are markedly downregulated in adult tissues where vasculature is quiescent (43) . Nevertheless, EIIIB-and EIIIA-null mice are viable and fertile (17, 57, 38) suggesting that embryonic vessel formation occurs normally in the absence of these splice variants. The animals appear largely normal, although small differences in wound healing, atherosclerosis and life-span have been reported for the EIIIA-null mice (57, 38) .
During angiogenesis following vascular injury in an adult, EIIIA and EIIIB FNs become upregulated around blood vessels (30, 55, 56) . In addition fibronectin and its splice variants become highly upregulated around blood vessels in many human tumors (8, 9, 11, 29, 31, 32, 34, 35, 40-42, 46, 52) . Indeed, these splice variants are sometimes called "oncofetal fibronectin isoforms" to signify their prominent expression in embryos and in tumors (51) . Inclusion of the EIIIB exon into FN mRNA has been considered as a marker of tumor angiogenesis (9) , and high affinity antibodies that bind to EIIIB + -FN have been shown to localize specifically to tumor vasculature (4, 58) .
In vitro and in vivo evidence suggests that EIIIA-FN might play a role in pericyte or smooth muscle cell development. In vitro experiments suggest that EIIIA-FN facilitates TGFβ1-mediated conversion of fibroblastic precursors into myofibroblasts expressing alpha smooth muscle actin (αSMA) (53) . In vivo, EIIIA-expressing endothelial cells have been shown to stimulate the conversion of lipocytes into αSMA-expressing myofibroblasts (30) . Pericytes share features with myofibroblasts and express αSMA upon maturation (26) . Intimate association of pericytes with blood vessel endothelial cells is important for vascular stability and integrity: normal and tumor vessels regress when association between endothelial cells and pericytes is blocked (1, 3) .
The high degree of amino acid sequence conservation of EIIIA and EIIIB fibronectins among species, their tightly regulated vascular pattern of expression, and the data on smooth muscle α-actin induction, suggest but do not prove that these splice variants play some important role in angiogenesis. To test this hypothesis, we examined physiological and tumor angiogenesis in mice that lack either EIIIA or EIIIB FNs. Physiological angiogenesis was examined in the context of new vessel growth in the mouse retina, and tumor angiogenesis was examined during pancreatic islet tumorigenesis in Rip1-Tag2 transgenic mice and in a subcutaneous tumor transplant model.
MATERIALS AND METHODS.

Animals. All experiments involving animals were approved by the MIT's Committee on Animal
Care and were done according to the guidelines of "Interdisciplinary Principles and Guidelines for the Use of Animals in Research, Marketing and Education". EIIIB-null and EIIIA-null mice were generated in the laboratories of Dr. Sekiguchi and Dr. George, respectively (17 and 57).
These mice were intercrossed with Rip1-Tag2 transgenic mice (24) Retinal Angiogenesis. Retinal angiography was performed as described (54) . Heterozygous and null EIIIB littermates on C57BL/6J background, and heterozygous and null EIIIA littermates (a mix of C57BL/6J and Balb/C strains) were used. Mice were anesthetized with 0.3g tribromoethanol at seven days after birth and injected with 200 µl of 50 mg/ml FITC-dextran (Sigma, molecular weight 10 6 g/mol) through the heart's left ventricle. Mice were then sacrificed and retinas were dissected. Five radial cuts were made in each retina for flat-mounting on slides.
Blood vessels were observed using a Zeiss Axiophot fluorescence microscope. Vessel density was evaluated using OpenLab software as the amount of fluorescence per 100 pixels (three to five areas of 5x10 4 -10x10 4 pixels covering almost the entire retina were analyzed in each case).
Large vessels were excluded from the analysis. At least four retinas of each genotype were analyzed. The box-plots were generated using a web-based program with [α-32 P]dUTP (6000 Ci/mmol, New England Nuclear). The reaction mixtures were resolved on 5% polyacrylamide gels containing urea, developed by autoradiography, and quantified using phosphorimager. Saturating amounts of probe were used, since we did not observe increase in signal when the amount of probe was doubled (data not shown).
RESULTS.
Physiological Angiogenesis. EIIIA-null and EIIIB-null mice are viable and fertile, suggesting that angiogenesis in these embryos occurs normally. RT-PCR analysis indicated that EIIIA-null and EIIIB-null embryos indeed lacked EIIIA or EIIIB exons in their FN mRNA (Fig. 1A, B) .
Furthermore, immunohistochemical analysis showed that EIIIB-null mice lack EIIIB-FN proteins ( Fig. 1 C, D) .
To examine a physiological process of angiogenesis that takes place after birth, we quantified blood vessel growth in the retinas of newborn mice. Mouse retinas, avascular at the time of birth, become vascularized during the first two postnatal weeks (54) . The vascularity of mouse retinas was assessed by evaluating the blood vessel density following intra-cardiac injection of FITC-dextran. We did not observe differences in blood vessel density between littermates of mice that carried heterozygous or homozygous deletion of EIIIB or EIIIA exons ( Fig. 2A, B) . The median vessel density in the retinas of animals with EIIIB or EIIIA deletion was 21 and 14.5 fluorescence units per 100 pixels, respectively. This difference in vessel density is probably due to strain-specific genetic factors that influence angiogenic response (49, 22) .
Since EIIIA-containing FNs have been implicated in vascular smooth muscle cell differentiation, we examined smooth muscle coverage of tail arteries in cross sections of tails from seven day-old mice (50) . Figure 2C shows that tail arteries from EIIIA or EIIIB-null mice are enclosed by smooth muscle cells to a similar extent as their heterozygous littermates. Taken together, these analyses show that the absence of EIIIA or EIIIB exons does not affect the physiological process of angiogenesis in mouse retinas, and that the formation of arterial smooth muscle layers is not affected by the absence of EIIIA or EIIIB.
Pathological Angiogenesis.
Expression of FN and its splice variants in murine tumor blood vessels. Fibronectin splice variants are highly upregulated in a variety of human tumors. To examine whether fibronectin proteins are similarly upregulated around tumor blood vessels in the Rip1-Tag2 murine tumor model, we stained sections of pancreas containing angiogenic islets and tumors with antibodies recognizing FN and its splice variants. Fibronectin is expressed around blood vessels in normal islets (Fig. 3 A) , but its expression becomes markedly increased around tumor blood vessels (Fig. 3 B) . Almost co-incident with this increase is a massive upregulation of αSMA (Fig. 3 A, B and Fig. 4 ), indicating the appearance of mature pericytes/vascular smooth muscle cells. This upregulation was confirmed by an increase in the number of cells expressing NG2, a different pericyte marker (compare Fig. 4 A and B) . Pericytes expressing NG2 are present around blood vessels in normal pancreatic islets as well as in tumors (Fig. 4A) . However, in tumors, NG2+pericytes are increased in abundance and co-express αSMA (Fig. 4B) . Confocal microscopy showed that tumor pericytes accumulate in the areas between tumor blood vessels, rich in extracellular matrix containing fibronectin and laminin (data not shown and, Fig. 4 C, D)
as described elsewhere (37) .
The expression of EIIIB-FN is also highly upregulated around tumor vasculature. EIIIB-FN is almost non-existent in the normal pancreas (data not shown and ref. 43 ) but becomes markedly increased in tumor vessels (Fig. 4 D) . Upregulation of EIIIB also coincides with the increase in the numbers of cells expressing NG2 and αSMA (Fig. 4B) . EIIIA-FN mRNA is also expressed in tumors as determined from RNAse protection experiments ( Figure 6A ). Taken together, these studies demonstrated that, as in human tumors, fibronectin and its splice variants are upregulated around tumor vasculature in mice.
Angiogenesis and Tumorigenesis in EIIIA-null and EIIIB-null mice.
To examine the roles of EIIIA-and EIIIB-FN in tumor angiogenesis, we used the Rip1-Tag2 transgenic mouse model, wherein islet cell carcinomas develop in the pancreas via a multistage pathway. In this model, neoplastic angiogenesis can be assessed quantitatively by determining the numbers of pancreatic islets that have undergone an angiogenic switch (15) . Despite the tight regulation of EIIIB and EIIIA expression during neoplastic transformation, the number of angiogenic islets in EIIIB-null and heterozygous mice as well as in EIIIA-null or heterozygous animals were not statistically different ( showed that RNA levels of other splice variants of fibronectin were not changed in the absence of EIIIA or EIIIB (Fig. 6 , and Table 1 ). Taken together, our studies indicate that the individual absence of EIIIA-or EIIIB-FN splice variants does not affect tumor angiogenesis or tumor growth in Rip1-Tag2 transgenic mice.
Previous in vitro and in vivo studies suggested that αSMA becomes upregulated in pericyte precursors stimulated with EIIIA-FN. To address whether or not EIIIA-FN is required to induce αSMA expression, we analyzed αSMA expression in EIIIA-null tumors by immunofluorescence (Fig. 7) , and quantified the levels of αSMA mRNA by RNAse protection (Table 1) . Both immunofluorescence and RNAse protection experiments showed that αSMA is expressed in pericytes around blood vessels in EIIIA-null and EIIIB-null tumors, and that the amount of αSMA mRNA was not affected by the absence of either EIIIA or EIIIB.
Growth of subcutaneous tumors in EIIIA-and EIIIB-null mice. Gene knockout and cell
biology experiments have shown that vessel growth may be affected by distinct players in different tissues (36, 13) . Therefore, we investigated whether the absence of EIIIA-or EIIIB-FN splice variants might play a role in tumors grown in a different site, under the skin. B16 mouse melanoma cells were injected into the subcutaneous space of EIIIB-or EIIIA-null mice that had been backcrossed onto C57BL/6J background, and tumor weight was assayed two weeks later. The lack of effect on angiogenesis in the EIIIA or EIIIB knock out mice was unexpected since there is a significant body of published data describing the upregulation of these splice variants around angiogenic and tumor blood vessels (see Introduction).
It is important to note that the correlation of expression of EIIIA and EIIIB FN splice variants with angiogenesis does not unequivocally prove that they are required for angiogenesis to take place. Only the analyses of mice lacking either of these two exons (57, 38, 17 and the present work) provide a direct test of functional relevance of these segments for in vivo angiogenesis and tumor growth. These analyses show clearly that, individually, neither of the splice variants is necessary for these processes.
Interestingly, EIIIA-null and EIIIB-null tumor vessels still contained cells expressing αSMA, andlevels of αSMA were the same in null and heterozygous animals. Arteries in the mouse tails from null and heterozygous animals in this study were also surrounded by smooth muscle layers to a similar extent. These results were unexpected, because some in vitro -bands protected with V120 and EIIIB probes, and lanes 3 and 6 -bands protected with EIIIA probe. Results of quantification relative to the intensity of β-actin band are presented in Table 1. B. RNAse protection analysis of EIIIB-null and heterozygous tumors. Lane1-undigested probes (V120, EIIIB, EIIIA, αSMA). These four probes were used simultaneously for RNAse protection. Lane 2-control hybridization using yeast RNA. In samples from EIIIB +/-and EIIIB -/-tumors, arrows point to V120, V95, EIIIB, EIIIA, and αSMA protected bands. Results of quantification relative to the intensity of β-actin band are presented in Table 1 . 
